The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 27, 2015
Filed:
Mar. 02, 2009
Applicants:
M. Edward Medof, Pepperpike, OH (US);
Michael G. Strainic, Westlake, OH (US);
Young a Choi, Shaker Heights, OH (US);
Inventors:
M. Edward Medof, Pepperpike, OH (US);
Michael G. Strainic, Westlake, OH (US);
Young A Choi, Shaker Heights, OH (US);
Assignee:
Case Western Reserve University, Cleveland, OH (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); C12N 15/11 (2006.01); A61K 38/00 (2006.01); C07K 16/28 (2006.01); C12N 15/113 (2010.01); A61K 38/08 (2006.01); A61K 38/10 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2896 (2013.01); C07K 2316/96 (2013.01); C12N 2310/14 (2013.01); A61K 39/395 (2013.01); A61K 38/00 (2013.01); A61K 38/08 (2013.01); C12N 15/1138 (2013.01); A61K 38/10 (2013.01); A61K 2039/505 (2013.01); A61K 39/00 (2013.01);
Abstract
A method for inducing apoptosis of a neoplastic cell expressing C3aR or C5aR includes administering at least one complement antagonist to the cell so that the at least one complement antagonist substantially reduces or inhibits the activity of protein kinase B in the neoplastic cell.
Medof, M.. (2015). Method of treating cancer (U.S. Patent No. 8940299). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8940299
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile